||EPS - Basic
||Market Cap (m)
|Health Care Equipment & Services
Real-Time news about Dawmed Sys (London Stock Exchange): 0 recent articles
|mjcrockett: Red letter day today! A post on the bulletin board AND the share price goes up.
I guess that we will see results this month.
|mjcrockett: Or is it a bit of a buying opportunity? I spoke to the company today and they know of no trading reason why the share price should fall. There is an article in Aimzine this month about Dawmed (I know, I wrote it). You can access the article by registering at www.aimzine.co.uk - it's free to register and only takes a couple of minutes.
|mjcrockett: The funny thing is that on Friday with the price quoted at 4.00/6.00 the actual price quoted to buy was 4.74p. Today, with the price quoted at 3.50/5.50, the buy price is 5.00p. Movements in the share price such as we are seeing now are purely marketmaker games.
I went to the Dawmed AGM on Friday. I think the AGM statement covers most of what was discussed. The company is seemingly recovering well from a bad year last year and the prospects look reasonably bright. In my view, the share price does not yet reflect the change in fortunes.
|mjcrockett: The share price has just ticked up 1/2p with the bid at 7p, but online you can now sell in quantity at 8p. The maximum to buy online is 1000 at 8.5p.
|gelp: Thanks for the information. If the bad debt can come back in the accounts then confidence would be restored somewhat and back on track. I still say over reaction to one debt and any analysis as to the integrity of that debt or late payment gives a pointer to the direction of the share price. Your post leads me to feel even more positive bout the issue.
The consumeables are very important. Gillette don't make money on the razors but the blades and with the hype about MRSA etc etc, sterilisation and 'through away consumables' are top subjects today.|
|mjcrockett: Gelp, not so long ago the spread here was 4 or 5p, so 2p is an improvement. I agree with you that Dawmed could be a takeover target. However, with directors owning over half of the shares any bid would need to be a lot lot higher than this. I believe that the directors want to build up the business (and the share price) before selling it.
|billbyrne: It must be because the markets are jittery at the moment.
200,000 shares bought and we are down 1p. It could be that
with the RNS last week the seller has finished so we should
be seeing the share price move up with that many shares bought.
Not many shares in issue so will move up quickly if there is
Have bought at 7 today - hate the spread but what the hell. I agree full time FD with credentials will greatly help things along. The failure in systems to allow running up a bad debt of such a size will surely be addressed. The low level of the share price may tempt opportunist stake building buy others in the health sector. Why wait for price to rise.Can't believe will dip below £1mil m/c! I expect some institution has got a bit impatient with the entrepreneurs but the new FD will help.|
|mjcrockett: Gelp, I think ridiculously cheap. Given what the company have said that they are confident about prospects for the current year, it would seem that the results next month will be reasonable. Also, 2007 should be a particularly good year for the company with new European regs coming in. Further, the appointment of a full time FD must show things are going pretty well. I have bought a few shares in recent weeks, but someone else has been selling. Perhaps, as you say, they have been spooked by the bad debt.
I agree that DSY would be attractive to others. However, with 2 founding directors having substantial stakes, I would not expect anything to happen until the share price has recovered substantially from these levels.
|mjcrockett: Vuelands, as far as I am aware there are no problems with the business, but the occasional seller has brought the price down and, as you say, the lack of news does not encourage buyers. It looks very possible that these will turn in a reasonable profit next year and if they do then we could see the share price increase dramatically from here. I have swapped emails recently with the exec chairman regarding the share price and he is frustrated by its poor performance. So I would hope to see a bit more publicity for the company over the winter months.
One point to note is that Dawmed have products and a lot of experience in their field, which currently is only sold in the UK. Two of their products could easily be sold abroad and with the right resellers there could be huge potential.
I suppose there is considerable risk in changing a business model as Dawmed have done recently and the market is reflecting this and waiting to see some results. But, the shares do seem incredibly cheap - IMO.
Dawmed Systems share price data is direct from the London Stock Exchange